Repeated complete response with long-term control of BRAF-mutant melanoma by multiple rechallenges with dabrafenib plus trametinib.

Sasaki, Katsuhito; Nakamura, Yasuhiro; Baba, Natsuki; Teramoto, Yukiko; Yamamoto, Akifumi

Sasaki, Katsuhito; Nakamura, Yasuhiro; Baba, Natsuki; Teramoto, Yukiko; Yamamoto, Akifumi.

Afiliação

Sasaki K; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
Nakamura Y; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan. Electronic address: ynakamur@saitama-med.ac.jp.
Baba N; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
Teramoto Y; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
Yamamoto A; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.

Eur J Cancer ; 139: 37-40, 2020 11.

Article em En | MEDLINE | ID: mdl-32957012

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Imidazóis/uso terapêutico; Melanoma/tratamento farmacológico; Melanoma/genética; Oximas/uso terapêutico; Proteínas Proto-Oncogênicas B-raf/genética; Piridonas/uso terapêutico; Pirimidinonas/uso terapêutico; Adulto; Feminino; Humanos; Mutação/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oximas / Piridonas / Pirimidinonas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas B-raf / Imidazóis / Melanoma Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google